The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
Open accessAbstract
Objective : Currently, there is no effective medical treatment for patients with pituitary-dependent Cushing’s disease. A novel somatostatin (SS) analogue, named SOM230, with high binding affinity to SS receptor subtypes sst 1 , sst 2 , sst 3 and sst 5 was recently introduced. We compared the in vitro effects of the sst 2 -preferring SS analogue octreotide (OCT) and the multi-ligand SOM230 on ACTH release by human and mouse corticotroph tumour cells. Methods : By quantitative RT-PCR the sst subtype expression level was determined in human corticotroph adenomas. In vitro , the inhibitory effect of OCT and SOM230 on ACTH release by dispersed human corticotroph adenoma cells and mouse AtT20 corticotroph adenoma cells was determined. In addition, the influence of dexamethasone on the responsiveness to OCT and SOM230 was studied. Results : Corticotroph adenomas expressed predominantly sst 5 mRNA (six out of six adenomas), whereas sst 2 mRNA expression was detected at significantly lower levels. In a 72 h incubation with 10 nmol/l SOM230, ACTH release was inhibited in three out of five cultures (range −30 to −40%). Ten nmol/l OCT slightly inhibited ACTH release in only one of five cultures (− 28%). In AtT20 cells, expressing sst 2 , sst 3 and sst 5 , SOM230 inhibited ACTH secretion with high potency (IC 50 0.2 nmol/l). Dexamethasone (10 nmol/l) pre-treatment did not influence the sensitivity of the cells to the inhibitory effect of SOM230, suggesting that sst 5 is relatively resistant to negative control by glucocorticoids. Conclusions: The selective expression of sst 5 receptors in corticotroph adenomas and the preferential inhibition of ACTH release by human corticotroph adenoma cells by SOM230 in vitro , suggest that SOM230 may have potential in the treatment of patients with pituitary-dependent Cushing’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Self-citationSomatostatin receptor subtype gene expression in pituitary adenomas
Miller, G. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1386 · Cited by 220
The Medical Treatment of Cushing's Syndrome
MILLER, J. W., & CRAPO, L. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-443 · Cited by 202
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
Panetta, R., & Patel, Y. C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00956-2 · Cited by 185
Hofland, L. J., van der Hoek, J., van Koetsveld, P. M., de Herder, W. W., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., Feelders, R., van der Lely, A.-J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031344 · Cited by 185
Self-citationHeterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.398 · Cited by 180
Weckbecker, G., Briner, U., Lewis, I., & Bruns, C. (2002) · Endocrinology · doi:10.1210/en.2002-220219 · Cited by 163
Self-citationInhibition of Adrenocorticotropin Secretion by Somatostatin in Pituitary Cells in Culture*
Richardson, U. I., & Schönbrunn, A. (1981) · Endocrinology · doi:10.1210/endo-108-1-281 · Cited by 133
Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis
Strowski, M. Z., Köhler, M. G., Chen, H. Y., Trumbauer, M. E., Li, Z., Szalkowski, D., Gopal-Truter, S., Fisher, J. K., Schaeffer, J. M., Blake, A. D., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2001-0035 · Cited by 130
INHIBITION BY SOMATOSTATIN OF ACTH SECRETION IN NELSON'S SYNDROME
Tyrrell, J. B., Lorenzi, M., Gerich, J. E., & Forsham, P. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-6-1125 · Cited by 124
Lewis, I., Bauer, W., Albert, R., Chandramouli, N., Pless, J., Weckbecker, G., & Bruns, C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021093t · Cited by 117
Self-citationGlucocorticoids Down-Regulate Somatostatin Receptors on Pituitary Cells in Culture*
Schönbrunn, A. (1982) · Endocrinology · doi:10.1210/endo-110-4-1147 · Cited by 109
Lamberts, S. W. J., Uitterlinden, P., & Klijn, J. M. G. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200760 · Cited by 109
Self-citationDay, R. W., Dong, W., Panetta, R., Kraicer, J., Greenwood, M. T., & Patel, Y. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588263 · Cited by 108
Central Nervous System Regulation of Adrenocorticotropin Secretion: Role of Somatostatins*
Brown, M. R., RIVIER, C. L., & Vale, W. (1984) · Endocrinology · doi:10.1210/endo-114-5-1546 · Cited by 103
Hofland, L. J., van Koetsveld, P. M., Waaijers, M., Zuyderwijk, J., Breeman, W. A. P., & Lamberts, S. W. J. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649075 · Cited by 100
Self-citationWidespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary
O’Carroll, A., & Krempels, K. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588261 · Cited by 100
Octreotide exerts different effects in vivo and in vitro in Cushing's disease
Stalla, G. K., Brockmeier, S. J., Renner, U., Newton, C., Buchfelder, M., Stalla, J., & Müller, O. A. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300125 · Cited by 96
The Medical Management of Cushing's Syndrome
Morris, D. G., & Grossman, A. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04418.x · Cited by 76
Ambrosi, B., Bochicchio, D., Fadin, C., Colombo, P., & Faglia, G. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349555 · Cited by 71
Strowski, M. Z., Dashkevicz, M. P., Parmar, R. M., Wilkinson, H. A., Köhler, M. G., Schaeffer, J. M., & Blake, A. D. (2002) · Neuroendocrinology · doi:10.1159/000059430 · Cited by 70
Hofland, L. J., Lamberts, S. W. J., van Hagen, P. M., Reubi, J., Schaeffer, J. M., Waaijers, M., van Koetsveld, P. M., Srinivasan, A., Krenning, E. P., & Breeman, W. A. P. (2003) · PubMed · Cited by 69
Self-citationSomatostatin: A potent inhibitor of ACTH-Hypersecretion in adrenal insufficiency
Fehm, H., Voigt, K. H., Lang, R., Beinert, K. E., Raptis, S., & Pfeiffer, E. F. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01468882 · Cited by 68
Lamberts, S. W. J., Zuyderwijk, J., den Holder, F. H., van Koetsveld, P. M., & Hofland, L. J. (2008) · Neuroendocrinology · doi:10.1159/000125200 · Cited by 68
Self-citationLamberts, S. W. J., de Herder, W. W., Krenning, E. P., & Reubi, J. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.1.7904612 · Cited by 63
Self-citationNew Medical Approaches in Pituitary Adenomas
Colao, A., Sarno, A. D., Marzullo, P., Somma, C. D., Cerbone, G., Landi, M. L., Faggiano, A., Merola, B., & Lombardi, G. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023539 · Cited by 62
Stroh, T., Jackson, A. C., Sarret, P., Farra, C. D., Vincent, J., Kreienkamp, H., Mazella, J., & Beaudet, A. (2000) · Endocrinology · doi:10.1210/endo.141.1.7259 · Cited by 58
Pituitary Disorders: Drug Treatment Options
Orrego, J. J., & Barkan, A. L. (2000) · Drugs · doi:10.2165/00003495-200059010-00006 · Cited by 55
Reisine, T. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21787-6 · Cited by 53
Nicholson, S. A., Adrian, T. E., Gillham, B., Jones, M. T., & Bloom, S. R. (1984) · Journal of Endocrinology · doi:10.1677/joe.0.1000219 · Cited by 45
Suda, T., Tomori, N., TOZAWA, F., Demura, H., & SHIZUME, K. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-5-840 · Cited by 44
Kraicer, J., Gajewski, T. C., & Moor, B. C. (2008) · Neuroendocrinology · doi:10.1159/000124203 · Cited by 42
Octapeptide somatostatin-analogue therapy of Cushing's syndrome
de Herder, W. W., & Lamberts, S. W. J. (1999) · Postgraduate Medical Journal · doi:10.1136/pgmj.75.880.65 · Cited by 42
Self-citationReisine, T. D., & Takahashi, J. S. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-03-00812.1984 · Cited by 38
Nielsen, S., Mellemkjær, S., Rasmussen, L. M., Ledet, T., Astrup, J., Weeke, J., & Jørgensen, J. O. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5046 · Cited by 37
Spada, A., REZA-ELAHI, F., Lania, A. G., BASSETTI, M., & ATTI, E. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1262 · Cited by 27
Stroh, T. (2000) · Endocrinology · doi:10.1210/en.141.1.354 · Cited by 23
Voigt, K. H., Fehm, H. L., Lang, R. E., & Walter, R. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90084-4 · Cited by 21
LITVIN, Y., Leiser, M., Fleischer, N., & Erlichman, J. (1986) · Endocrinology · doi:10.1210/endo-119-2-737 · Cited by 14
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Self-citationA 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
Metadata
- Authors
- Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., Beckers, A., & Lamberts, S. W. J.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04
- Volume
- 152
- Issue
- 4
- Pages
- 645-654
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2123601063
- Cited by
- 276
- References
- 42
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.